
Zumutor Biologics
Bangalore, India zumutor.com From their website, Nov 2026
- ISO 9001
Work here? Claim this listing
About
Zumutor Biologics discovers and develops monoclonal antibody therapeutics, with a focus on immuno-oncology and targeted NK cell biology. It is headquartered in Cambridge, Massachusetts, USA, and has an R&D laboratory in Bangalore, India.
Services
Bespoke analytical and process development
Provides a flexible full-service vertical for analytical and process development.
Discovery and development support for monoclonal antibodies
Offers differentiated services to support partners’ discovery programs and co-development of monoclonal antibodies.
Antibody discovery using INABLR®
Uses its proprietary antibody discovery platform to identify novel immunotherapies and improved monoclonal antibodies.
ADCC improvement platform services
Develops expression platforms intended to improve antibody-dependent cellular cytotoxicity of therapeutic antibodies.
Capabilities
- Assays and studies
- Antibodies
- Cell therapy
- Process development
- ADCC
- Efficacy studies
- MOA studies
- Ex-vivo studies
- Translational data studies
- Scale and capacity
- 250L scale
- Therapeutic areas
- Immuno-oncology
- Solid tumors
- Breast cancer
Modalities and species
- Modalities
- Antibody
- Cell therapy
- Species and models
- Xenograft models
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001:2008Self-reported
Scope: laboratory in Bangalore, India
GLPSelf-reported
Details
- Founded
- 2015
- Based in
- Bangalore, India
- Sites
- Cambridge, MA, USA
- Woburn, MA, USA
- Serves
- US
Public records
- Parent company
- ZUMUTOR BIOLOGICS PRIVATE LIMITED · IN GLEIF